MENJONG SORIG
PHARMACEUTICALS
Menjong Sorig Pharmaceuticals was then functioning as Pharmacy unit as a cottage manufacturing facility after the establishment of Hospital in Kawangjangsa, Thimphu in 1978. The Pharmacy unit for Traditional Medicines was established in 1982 through World Health Organization funding in procuring basic manufacturing equipments such as first grinding machine, rotary tablet press, coating pan mixer and sieving machines, oven. During those days, the manufacturing of traditional medicines was run by Menpa until the recruitment of first batch of four Pharmacy Technicians.
Achievements
» The signing of the share transfer agreement between the Ministry of Finance (MoF) and DHI on 9th April 2021 was an important milestone as the MSPCL became the latest entrant into DHI as one of its DHI companies.
» MSPCL’s Service Rules and Regulations (SRR) were harmonized with DHI’s standard guideline for DOCs on the development of SRR.
» On bio-prospecting and R&D front the Company introduced Black Turmeric in the local market after successful trial production.
» The trial production of one cannabis-related product was also carried out. Its commercial name is Menzang Analgesic Balm. It’s for external application only which is used to relieve pain and swelling.
Company | Particulars | 2021 | 2020 |
|---|---|---|---|
MSPCL | Total Assets | 177.07 M | 167.32 M |
Net Worth | 162.50 M | 153.48 M | |
Income | 77.12 M | 65.32 M | |
Expenditure | 70.14 M | 76.90 M | |
PBT | 6.97 M | (11.57) M | |
Tax | (2.22) M | (1.14) M | |
PAT | 9.19 M | (10.42) M |